SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...
The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...
Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
The 13th Annual International Symposium on Dissolution Science and Applications – DISSO INDIA 2025, organized by the Society for Pharmaceutical Dissolution Science (SPDS), in collaboration with SVKM's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback